ABLYSINOL

Peak

alcohol

NDAINTRA-ARTERIALSOLUTION
Approved
Jun 2018
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

intra-arterial catheter into a target septal vessel, which causes the hypertrophied septum to thin.

Clinical Trials (5)

NCT07428538Phase 3Recruiting

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

Started Jan 2026
NCT07255781N/AWithdrawn

Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy

Started Nov 2025
0
Psoriasis (PsO)PsA (Psoriatic Arthritis)NAFLD (Nonalcoholic Fatty Liver Disease)
NCT07216872N/ARecruiting

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)

Started Nov 2025
NCT07219953Phase 3Recruiting

A Study of Brenipatide in Participants With Alcohol Use Disorder

Started Oct 2025
1,100 enrolled
Alcohol Use Disorder
NCT07219966Phase 3Recruiting

A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

Started Oct 2025
1,100 enrolled
Alcohol Use Disorder